Rachel Occhiogrosso Abelman, Shannon McLaughlin, Geoffrey G. Fell, Ana Christina Garrido-Castro, Filipa Lynce, Lorenzo Trippa, Philip Daniel Poorvu, Aron S. Rosenstock, Arielle J. Medford, Seth Andrew Wander, Amy H. Comander, Steven J. Isakoff, Beverly Moy, Nadine M. Tung, Elizabeth A. Mittendorf, Leif Ellisen, Sara M. Tolaney, Aditya Bardia, Laura Spring. "A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.511